 |
인쇄하기
취소
|
Dong-A’s Stillen to be exposed to fiercer competition
The homegrown drug in Korea will not be as stale as before with a growing number of pharmaceutical companies poising to enter a 70 billion Stillen market.
More than 20 pharmaceutical manufacturers are expected to release the first version of Stillen capsule, one of Dong-A’s flagship products for treatment of gastritis, as the re-examination period of this medicine expired on June 11.
Cho...
More than 20 pharmaceutical manufacturers are expected to release the first version of Stillen capsule, one of Dong-A’s flagship products for treatment of gastritis, as the re-examination period of this medicine expired on June 11.
Cho...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.